Health and Work Ability After Inpatient Treatment for Stress-Related Disorders: Follow-Up of the HARMODI Cohort
Official title: Health and Work Ability Following Inpatient Treatment for Stress-related Disorders - Follow-up Study of the HARMODI Cohort
Run by Clinica Holistica Engiadina · NCT07757997 · Data updated 2026-11-12
This study follows people who had inpatient treatment for stress-related disorders to see how their health and ability to work change over the next three years and what factors help them return to work.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 143 (estimated) |
| Sponsor | Clinica Holistica Engiadina Academic / other |
| Locations | 2 sites (Süs and 1 other locations) |
| Status | Recruiting |
| Started | August 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT07757997 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who previously participated in the HARMODI study and completed inpatient treatment at Clinica Holistica Engiadina.
✕Probably not a fit
Individuals who did not participate in the original HARMODI study or who cannot be reached for follow-up may not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a monocentric, retrospective longitudinal study of the HARMODI cohort at Clinica Holistica Engiadina. Researchers will collect online questionnaires up to three years after discharge to track health, work ability, and return-to-work progress, building on previously measured cardiorespiratory fitness, HRV, and cognitive function. The aim is to identify predictors of long-term health trajectories and work re-entry to inform treatment optimization and public health policy. The study combines self-reported outcomes with prior objective assessments to provide a comprehensive view of long-term recovery from stress-related disorders. It is observational in nature, with no specified interventions during the follow-up period.
Why it matters
Potential benefit: If successful, the study could illuminate factors that support sustained work ability and inform improvements in post-treatment care for stress-related disorders.
How similar studies have gone: Previous research suggests long-term health and return-to-work trajectories after inpatient treatment can vary, and this study seeks to add detailed long-term insight in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Previously participatiom in the HARMODI study (No. 2022-01871) * Completion of inpatient treatment at the Clinica Holistica Engiadina Exclusion Criteria: * Withdraw of consent for participation in the HARMODI study. * Participants who cannot be reached despite predefined contact attempts (e.g., invalid email or postal address or telephone number)
Where it's running
-
Clinica Holistica Engiadina
Süs, Switzerland Recruiting -
Clinica Holistica Engiadina
Süs, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Namir Lababidi, Dipl. — Clinica Holistica Engiadina
- Study coordinator: Wiebke Turner, MoA
- Email: wiebke.turner@clinica-holistica.ch
- Phone: 0813002030
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Medically tailored groceries to help depression in people with food insecurity
This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.
-
ADAPT: a new parenting program to help depressed parents improve their kids’ behavior
A new parenting program called ADAPT tests whether tailored support for parents with depression helps reduce their child’s emotional and behavioral problems better than the standard Incredible Years Parenting Program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.